Lyell Immunopharma is a biotechnology company dedicated to advancing the field of cancer immunotherapy. Founded in 2018, the company focuses on developing innovative technologies to engineer T cells for enhanced anti-tumor activity. With a mission to revolutionize cancer treatment, Lyell Immunopharma is at the forefront of creating personalized cell therapies to combat a wide range of cancers.

Senior Manager, Flow Cytometry

Specialist, Quality Control

Scientist I, T Cell Stemness

Senior IT Security Specialist

Vice President - Process Sciences

Director, Pathology

Vice President, Process Sciences

Senior Director, Pharmacovigilance Operations

GMP QC Specialist

Principal Systems Adminstrator

lyell_immunopharma

Refer new talent to Lyell Immunopharma